Skip to content
Search

Latest Stories

Type 2 Diabetes Path to Remission Programme to be rolled out across England

Type 2 Diabetes Path to Remission Programme to be rolled out across England

Over 1,150 people with type 2 diabetes and obesity or overweight in the West Midlands have benefited from this programme

NHS England is expanding the Type 2 Diabetes Path to Remission Programme across the country from April 2024, following the successful pilot launch in the Midlands.


A joint initiative between NHSE and Diabetes UK, the programme offers a low calorie, total diet replacement treatment for individuals who are living with type 2 diabetes and obesity or overweight.

More than 1,150 patients in the West Midlands have joined the programme and benefited from it since its introduction in 2020 until February 2024.

Previously known as the NHS Low Calorie Diet Programme, this evidence-based intervention is aimed at reversing diabetes and maintaining weight loss in the long term.

“This is such a great chance for people to take control of their health and to put their type 2 diabetes into remission,” said Professor Vinod Patel, West Midlands Clinical Lead for NHS England (Midlands) for Diabetes.

Peter Shorrick, head of Midlands and East at Diabetes UK, explained that achieving remission can help reduce the risk of developing serious problems with the eyes, feet, or heart in many patients with type 2 diabetes, while also providing hope for a medication-free future.

“People in remission say it’s life changing and we funded research that shows that this programme works.

“Our aim is to support people to go on the Path to Remission Programme and achieve results safely, complementing it with our advice on a range of issues from maintaining a healthy diet, to exercise, mental health and the importance of peer-to-peer support to provide a holistic approach,” he added.

This programme is based on research that found a 3-month specially formulated ‘soup and shake’ diet, coupled with healthy lifestyle support, helped people living with type 2 diabetes and obesity or overweight to lose over 10kg (1st  5lbs) in weight, improve their blood glucose levels, reduce diabetes-related medication and achieve remission of type 2 diabetes in almost half of the participants.

People aged 18 – 65 years who have been diagnosed with type 2 diabetes within the last six years, and have a BMI over 27 kg/m2 (for individuals from White ethnic groups) or over 25 kg/m2 (for individuals from Black, Asian and other ethnic groups) are eligible to participate in the NHS Type 2 Diabetes Path to Remission Programme.

James from Birmingham has lost 95kg (54 per cent of his body weight) since starting the programme in 2021.

“I now weigh 82kg. With a Hb1Ac (average blood glucose) of 29, my diabetes is in remission and my GP has advised me that I don’t need any diabetes treatment which is fantastic,” James said.

He was referred to the programme by a nurse practitioner from his GP surgery due to difficulties tolerating his medications. At that time, his weight was 177kg (27st 8 lbs).

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less